EP3597256A1 - Stent intégré présentant une boucle de repositionnement et d'extraction - Google Patents
Stent intégré présentant une boucle de repositionnement et d'extraction Download PDFInfo
- Publication number
- EP3597256A1 EP3597256A1 EP19185559.2A EP19185559A EP3597256A1 EP 3597256 A1 EP3597256 A1 EP 3597256A1 EP 19185559 A EP19185559 A EP 19185559A EP 3597256 A1 EP3597256 A1 EP 3597256A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- stent
- wires
- loop
- wire
- retrieval
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims description 30
- 238000009954 braiding Methods 0.000 claims description 24
- 239000000463 material Substances 0.000 description 46
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 34
- 229910001000 nickel titanium Inorganic materials 0.000 description 28
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 28
- 229910052697 platinum Inorganic materials 0.000 description 17
- -1 polyethylene Polymers 0.000 description 17
- 239000011248 coating agent Substances 0.000 description 15
- 238000000576 coating method Methods 0.000 description 15
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 13
- 239000010931 gold Substances 0.000 description 13
- 229910052737 gold Inorganic materials 0.000 description 13
- 229920001296 polysiloxane Polymers 0.000 description 13
- 239000002131 composite material Substances 0.000 description 11
- 229910052715 tantalum Inorganic materials 0.000 description 11
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 11
- 229910001220 stainless steel Inorganic materials 0.000 description 10
- 239000010935 stainless steel Substances 0.000 description 9
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 8
- 239000010936 titanium Substances 0.000 description 8
- 229910052719 titanium Inorganic materials 0.000 description 8
- 238000003466 welding Methods 0.000 description 7
- 229910000531 Co alloy Inorganic materials 0.000 description 6
- 229910052741 iridium Inorganic materials 0.000 description 6
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 6
- 229910052758 niobium Inorganic materials 0.000 description 6
- 239000010955 niobium Substances 0.000 description 6
- GUCVJGMIXFAOAE-UHFFFAOYSA-N niobium atom Chemical compound [Nb] GUCVJGMIXFAOAE-UHFFFAOYSA-N 0.000 description 6
- 239000004698 Polyethylene Substances 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- 230000036961 partial effect Effects 0.000 description 5
- 229920000573 polyethylene Polymers 0.000 description 5
- 229920001244 Poly(D,L-lactide) Polymers 0.000 description 4
- 239000004743 Polypropylene Substances 0.000 description 4
- 238000005452 bending Methods 0.000 description 4
- 229920000295 expanded polytetrafluoroethylene Polymers 0.000 description 4
- 239000003102 growth factor Substances 0.000 description 4
- 229920001432 poly(L-lactide) Polymers 0.000 description 4
- 229920000728 polyester Polymers 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 229920000417 polynaphthalene Polymers 0.000 description 4
- 229920001155 polypropylene Polymers 0.000 description 4
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 4
- 229920002635 polyurethane Polymers 0.000 description 4
- 239000004814 polyurethane Substances 0.000 description 4
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 3
- 239000000956 alloy Substances 0.000 description 3
- 239000003146 anticoagulant agent Substances 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000008602 contraction Effects 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 229920001610 polycaprolactone Polymers 0.000 description 3
- 239000004632 polycaprolactone Substances 0.000 description 3
- 239000004810 polytetrafluoroethylene Substances 0.000 description 3
- 230000007704 transition Effects 0.000 description 3
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 2
- 101710112752 Cytotoxin Proteins 0.000 description 2
- 229940123011 Growth factor receptor antagonist Drugs 0.000 description 2
- 229920000331 Polyhydroxybutyrate Polymers 0.000 description 2
- 229960001138 acetylsalicylic acid Drugs 0.000 description 2
- 229910045601 alloy Inorganic materials 0.000 description 2
- 230000000702 anti-platelet effect Effects 0.000 description 2
- 239000004019 antithrombin Chemical class 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 230000001588 bifunctional effect Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 231100000599 cytotoxic agent Toxicity 0.000 description 2
- 239000002619 cytotoxin Substances 0.000 description 2
- 229910000701 elgiloys (Co-Cr-Ni Alloy) Inorganic materials 0.000 description 2
- 238000005530 etching Methods 0.000 description 2
- 229960002897 heparin Drugs 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000007769 metal material Substances 0.000 description 2
- 229920001245 poly(D,L-lactide-co-caprolactone) Polymers 0.000 description 2
- 239000005015 poly(hydroxybutyrate) Substances 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000012781 shape memory material Substances 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 210000005167 vascular cell Anatomy 0.000 description 2
- PUDHBTGHUJUUFI-SCTWWAJVSA-N (4r,7s,10s,13r,16s,19r)-10-(4-aminobutyl)-n-[(2s,3r)-1-amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2r)-2-amino-3-naphthalen-2-ylpropanoyl]amino]-16-[(4-hydroxyphenyl)methyl]-13-(1h-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-p Chemical compound C([C@H]1C(=O)N[C@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(N[C@@H](CSSC[C@@H](C(=O)N1)NC(=O)[C@H](N)CC=1C=C2C=CC=CC2=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(N)=O)=O)C(C)C)C1=CC=C(O)C=C1 PUDHBTGHUJUUFI-SCTWWAJVSA-N 0.000 description 1
- ZKMNUMMKYBVTFN-HNNXBMFYSA-N (S)-ropivacaine Chemical compound CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C ZKMNUMMKYBVTFN-HNNXBMFYSA-N 0.000 description 1
- SUNMBRGCANLOEG-UHFFFAOYSA-N 1,3-dichloroacetone Chemical compound ClCC(=O)CCl SUNMBRGCANLOEG-UHFFFAOYSA-N 0.000 description 1
- LEBVLXFERQHONN-UHFFFAOYSA-N 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide Chemical compound CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C LEBVLXFERQHONN-UHFFFAOYSA-N 0.000 description 1
- VNDNKFJKUBLYQB-UHFFFAOYSA-N 2-(4-amino-6-chloro-5-oxohexyl)guanidine Chemical compound ClCC(=O)C(N)CCCN=C(N)N VNDNKFJKUBLYQB-UHFFFAOYSA-N 0.000 description 1
- 102400000068 Angiostatin Human genes 0.000 description 1
- 108010079709 Angiostatins Proteins 0.000 description 1
- IYMAXBFPHPZYIK-BQBZGAKWSA-N Arg-Gly-Asp Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O IYMAXBFPHPZYIK-BQBZGAKWSA-N 0.000 description 1
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 description 1
- OMFXVFTZEKFJBZ-UHFFFAOYSA-N Corticosterone Natural products O=C1CCC2(C)C3C(O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 OMFXVFTZEKFJBZ-UHFFFAOYSA-N 0.000 description 1
- 102400001047 Endostatin Human genes 0.000 description 1
- 108010079505 Endostatins Proteins 0.000 description 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
- 102000007625 Hirudins Human genes 0.000 description 1
- 108010007267 Hirudins Proteins 0.000 description 1
- UETNIIAIRMUTSM-UHFFFAOYSA-N Jacareubin Natural products CC1(C)OC2=CC3Oc4c(O)c(O)ccc4C(=O)C3C(=C2C=C1)O UETNIIAIRMUTSM-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229930012538 Paclitaxel Natural products 0.000 description 1
- NTUPOKHATNSWCY-JYJNAYRXSA-N Phe-Pro-Arg Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)C1=CC=CC=C1 NTUPOKHATNSWCY-JYJNAYRXSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 1
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
- JXLYSJRDGCGARV-WWYNWVTFSA-N Vinblastine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-WWYNWVTFSA-N 0.000 description 1
- BROYGXJPKIABKM-UHFFFAOYSA-N [Ta].[Au] Chemical compound [Ta].[Au] BROYGXJPKIABKM-UHFFFAOYSA-N 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 230000001028 anti-proliverative effect Effects 0.000 description 1
- 239000003529 anticholesteremic agent Substances 0.000 description 1
- 229940127226 anticholesterol agent Drugs 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 108010072041 arginyl-glycyl-aspartic acid Proteins 0.000 description 1
- FZCSTZYAHCUGEM-UHFFFAOYSA-N aspergillomarasmine B Natural products OC(=O)CNC(C(O)=O)CNC(C(O)=O)CC(O)=O FZCSTZYAHCUGEM-UHFFFAOYSA-N 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 210000000013 bile duct Anatomy 0.000 description 1
- 210000003445 biliary tract Anatomy 0.000 description 1
- 239000012867 bioactive agent Substances 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 229960004436 budesonide Drugs 0.000 description 1
- 229960003150 bupivacaine Drugs 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000005229 chemical vapour deposition Methods 0.000 description 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 1
- 229960004316 cisplatin Drugs 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 230000001595 contractor effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- OMFXVFTZEKFJBZ-HJTSIMOOSA-N corticosterone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OMFXVFTZEKFJBZ-HJTSIMOOSA-N 0.000 description 1
- 238000002788 crimping Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229930013356 epothilone Natural products 0.000 description 1
- HESCAJZNRMSMJG-KKQRBIROSA-N epothilone A Chemical class C/C([C@@H]1C[C@@H]2O[C@@H]2CCC[C@@H]([C@@H]([C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)O1)O)C)=C\C1=CSC(C)=N1 HESCAJZNRMSMJG-KKQRBIROSA-N 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 229960002949 fluorouracil Drugs 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 239000003966 growth inhibitor Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000002628 heparin derivative Substances 0.000 description 1
- WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 description 1
- 229940006607 hirudin Drugs 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 238000009940 knitting Methods 0.000 description 1
- 108010021336 lanreotide Proteins 0.000 description 1
- 229960002437 lanreotide Drugs 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 229910000734 martensite Inorganic materials 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- KBOPZPXVLCULAV-UHFFFAOYSA-N mesalamine Chemical compound NC1=CC=C(O)C(C(O)=O)=C1 KBOPZPXVLCULAV-UHFFFAOYSA-N 0.000 description 1
- 229960004963 mesalazine Drugs 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000003604 miotic agent Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229960001592 paclitaxel Drugs 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000000106 platelet aggregation inhibitor Substances 0.000 description 1
- 229920006209 poly(L-lactide-co-D,L-lactide) Polymers 0.000 description 1
- 229920006210 poly(glycolide-co-caprolactone) Polymers 0.000 description 1
- 229920002463 poly(p-dioxanone) polymer Polymers 0.000 description 1
- 229920002627 poly(phosphazenes) Polymers 0.000 description 1
- 239000000622 polydioxanone Substances 0.000 description 1
- 229920002643 polyglutamic acid Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 229960005205 prednisolone Drugs 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 239000002089 prostaglandin antagonist Substances 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 229940044551 receptor antagonist Drugs 0.000 description 1
- 239000002464 receptor antagonist Substances 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 229960001549 ropivacaine Drugs 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- NCEXYHBECQHGNR-QZQOTICOSA-N sulfasalazine Chemical compound C1=C(O)C(C(=O)O)=CC(\N=N\C=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-QZQOTICOSA-N 0.000 description 1
- 229960001940 sulfasalazine Drugs 0.000 description 1
- NCEXYHBECQHGNR-UHFFFAOYSA-N sulfasalazine Natural products C1=C(O)C(C(=O)O)=CC(N=NC=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-UHFFFAOYSA-N 0.000 description 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
- 239000003803 thymidine kinase inhibitor Substances 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 108091006106 transcriptional activators Proteins 0.000 description 1
- 108091006107 transcriptional repressors Proteins 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 229960005356 urokinase Drugs 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 229960003048 vinblastine Drugs 0.000 description 1
- JXLYSJRDGCGARV-XQKSVPLYSA-N vincaleukoblastine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-XQKSVPLYSA-N 0.000 description 1
- 229960004528 vincristine Drugs 0.000 description 1
- OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 description 1
- OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/844—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents folded prior to deployment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2002/9528—Instruments specially adapted for placement or removal of stents or stent-grafts for retrieval of stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2002/9534—Instruments specially adapted for placement or removal of stents or stent-grafts for repositioning of stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0014—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0004—Rounded shapes, e.g. with rounded corners
- A61F2230/0013—Horseshoe-shaped, e.g. crescent-shaped, C-shaped, U-shaped
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0069—Three-dimensional shapes cylindrical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0039—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in diameter
Definitions
- the present invention relates to devices, methods and systems for retrieval and/or repositioning of an implanted stent. More particularly, the present invention relates to implantable stents having a stent retrieval member or loop for easy retrieval and/or repositioning of the implanted stent
- An intraluminal prosthesis is a medical device used in the treatment of diseased bodily lumens.
- One type of intraluminal prosthesis used in the repair and/or treatment of diseases in various body vessels is a stent
- a stent is a generally longitudinal tubular device formed of biocompatible material which is useful,to open and support various lumens in the body.
- stents may be used in the vascular system, urogenital tract, esophageal tract, tracheal/bronchial tubes and bile duct, as well as in a variety of other applications in the body. These devices are implanted within the vessel to open and/or reinforce collapsing or partially occluded sections of the lumen.
- Stents generally include an open flexible configuration. This configuration allows the stent to be inserted through curved vessels. Furthermore, this configuration allows the stent to be configured in a radially compressed state for intraluminal catheter implantation. Once properly positioned adjacent the damaged vessel, the stent is radially expanded so as to support and reinforce the vessel. Radial expansion of the stent may be accomplished by inflation of a balloon attached to the catheter or the stent may be of the self-expanding variety which will radially expand once deployed.
- Structures which have been used as intraluminal vascular grafts have included coiled stainless steel springs; helically wound coil springs manufactured from a heat-sensitive material; and expanding stainless steel stents formed of stainless steel wire in a zig-zag pattern.
- U.S. Patent No. 5,643,277 to Soehendra et al. describes the use of a tapered, threaded cable for removal of an implanted stent.
- the threaded portion of the cable is described as being twisted to engage an implanted biliary stent, such as a polyethylene stent, and then pulled to remove the sent from the patient.
- U.S. Patent No. 6,676,692 to Rabkin et al. describes a catheter system having stent-capturing hooks. The hooks are described as being useful for engaging the stent, thereby allowing repositioning and/or retrieval of the stent.
- U.S. Patent Application Publication No. 2002/0188344 A1 to Bolea et al. describes the use of hinged hooks attached to interior portions of an implantable stent Use of a retrieval tool is described as engaging the hooks, and, upon twisting of the retrieval tool, the stent is contracted thereby allowing retrieval of the stent.
- a wire lasso is described as being secured to an implantable stent with the wire lasso having a small loop internally disposed within the open lumen of the stent. The loop of the lasso is described as being engaged by a retrieval tool, and, upon twisting of the retrieval tool, the stent is contracted thereby allowing retrieval of the stent.
- FIG. 1 Other embodiments include a lasso wire threaded through eyelets at a stent end.
- a retrieval tool is described as engaging the lasso wire, and, upon twisting or axially pulling the lasso wire, the stent is contracted thereby allowing retrieval of the stent.
- Prior retrieval systems may appear easy to use, but often require certain user-sensitive techniques, such as twisting or turning in order to reposition or remove the stent.
- certain user-sensitive techniques such as twisting or turning in order to reposition or remove the stent.
- the spacing between conventional stent segments is generally smaller than the size of standard forceps or graspers, making it even difficult to grab a hook or lasso.
- the present invention provides a stent, for example a braided stent, having an integral repositioning and/or retrieval loop.
- the stent includes at least two elongate wires interlooped to form a tubular stent having opposed first and second open ends with each open end having a circumference, wherein one of the at least two wires is formed into a repositioning and/or retrieval loop having an elongated portion circumferentially disposed at the first opposed open end.
- the at least interlooped two wires are braided.
- the elongated circumferential portion of the reposition and/or retrieval loop may include a wire loop substantially traversing the first circumference.
- the elongated circumferential portion of the reposition and/or retrieval loop may further include a wire loop partially traversing the first circumference.
- the elongated circumferential portion of the reposition and/or retrieval loop includes a first wire loop substantially traversing the first circumference formed from one of the stent wires and a second wire loop partially traversing the first circumference formed from another of the stent wires, wherein the circumferential portion of the second wire loop is juxtaposingly disposed to a portion of the circumferential portion of the first wire loop.
- the first wire at the circumferential portion of the first wire loop may cross over the second wire at the circumferential portion of the second wire loop.
- the first wire at the circumferential portion of the first wire loop may be attached to the second wire at the circumferential portion of the second wire loop.
- the wires include biocompatible metallic and/or polymeric materials.
- Useful materials include nitinol, cobalt-based alloy, stainless steel, platinum, gold, titanium, tantalum, niobium, polymeric and combinations thereof.
- the wires include nitinol.
- the wires may be composite wires for improved radiopacity. Such composite wires may have an inner core of tantalum, gold, platinum, iridium or combination of thereof and an outer portion of nitinol.
- a braided stent having an integral repositioning and/or retrieval loop includes a plurality of wires having first and second ends interbraided in a braided pattern to form a tubular stent having opposed atraumatic first and second open ends with each open end having a circumference; wherein the first and second wires ends are disposed at the second stent open end and the wires are looped at the second stent open end so that none of the first or second wires ends are exposed at the circumference of second stent open end; wherein at least of two of the wires are formed into a repositioning and/or retrieval loop having an elongated portion circumferentially disposed at the first opposed open end; and wherein the reposition and/or retrieval loop includes two sections which run adjacent to each other prior to crossing to permit grabbing of both sections simultaneously by a practitioner.
- the first section of the reposition and/or retrieval loop may include a first wire loop substantially traversing the first circumference formed from one of the stent wires; and the second section of the reposition and/or retrieval loop may include a second wire loop partially traversing the first circumference formed from another of the stent wires, wherein the circumferential portion of the second wire loop is juxtaposingly disposed to a portion of the circumferential portion of the first wire loop.
- the second wire loop includes two legs longitudinally extending from the interbraided portion of the stent
- the legs may include a base and an apex, wherein the base is integral with the interbraided portion of the stent and where the wire is angularly bent at the apices to form the circumferential portion of the second wire loop.
- the first wire at the circumferential portion of the first wire loop crosses over the second wire at the circumferential portion of the second wire loop.
- the first wire at the circumferential portion of the first wire loop may also be attached to the second wire at the circumferential portion of the second wire loop.
- the wires at the first stent end may have an angular bend defining the initial portion of the braided pattern.
- the first wire at the circumferential portion of the first wire loop may cross over at least one of the angular bends at the first stent end or the first wire at the circumferential portion of the first wire loop may be attached to at least one of the angular bends at the first stent end.
- the wires may be made from biocompatible metallic and/or polymeric materials.
- the wire materials are selected from the group consisting of nitinol, cobalt-based alloy, stainless steel, platinum, gold, titanium, tantalum, niobium, polymeric and combinations thereof.
- the wires include nitinol.
- the wires may be composite wires for improved radiopacity.
- the composite wires may have an inner core of tantalum, gold, platinum, iridium or combination of thereof and an outer portion of nitinol.
- the stent includes an even number of wires from about 10 to about 36.
- the stent may further include a hollow tubular covering disposed over the interior or the exterior surface.
- the tubular covering may be an uninterrupted covering.
- the tubular covering may substantially cover the stent.
- the tubular covering may partially cover portions of the stent Desirably, the tubular covering substantially covers the stent, excluding portions of the repositioning and/or retrieval loop.
- the covering is a polymeric material.
- Useful polymeric materials may include polyester, polypropylene, polyethylene, polyurethane, polynaphthalene, polytetrafluoroethylene, expanded polytetrafluoroethylene, silicone, and combinations thereof.
- a method for producing a tubular braided stent having opposed first and second stent ends and having an integral repositioning and/or retrieval loop at the first stent end includes the steps of selecting a plurality of elongate biocompatible wires having opposed ends; forming a reposition and/or retrieval loop from two of the wires including two sections which run adjacent to each other prior to crossing to permit grabbing of both sections simultaneously by a practitioner; and braiding the wires to form the stent.
- the step for forming the reposition and/or retrieval loop may further include forming a first section by circumferentially disposing one wire prior to braiding.
- the step for forming the reposition and/or retrieval loop may further include forming a second section by circumferentially disposing a second wire and angularly bending the second wire to form two longitudinally legs prior to braiding.
- the step of braiding the wires may further include braiding the wires such that the opposed wires ends terminate at the second end of the stent.
- the method may further include bending the wires at the second end to form wire loops thereat.
- the method may further include welding the wire ends to form closed wire loops thereat. Desirably, the wire ends are welded proximal to a portion of the closed wire loops.
- the wire ends may be welded at a braided wire portion located proximally, but before, the closed wire loop ends.
- the step of selecting wires further includes selecting an even number of wires.
- the even number of wires may be from about 10 to about 36.
- the wires at the first end of the stent are angularly bent prior to the step of braiding so that no wire ends are disposed at the first end of the stent
- the wires at the first end of the stent may be angularly bent to form wire bends prior to the step of braiding so that no wire ends are disposed at the first end of the stent, and further wherein the one wire forming the first section crosses over at least one of the wire bends.
- a method of repositioning and/or retrieving an implantable stent includes the steps of providing a stent, which includes a plurality of wires having first and second ends interbraided in a braided pattern to form a tubular stent having opposed atraumatic first and second open ends with each open end having a circumference; wherein the first and second wires ends are disposed at the second stent open end and the wires are looped at the second stent open end so that none of the first or second wires ends are exposed at the circumference of second stent open end; wherein at least of two of the wires are formed into a repositioning and/or retrieval loop having an elongated portion circumferentially disposed at the first opposed open end; and wherein the reposition and/or retrieval loop includes two sections which run adjacent to each other prior to crossing; and grabbing of both sections the reposition and/or retrieval loop simultaneously to reposition and/or retrieve the
- the stent in another aspect of the present invention, uses of an implantable stent having a repositioning and/or retrieving loop.
- the stent includes a plurality of wires having first and second ends interbraided in a braided pattern to form a tubular stent having opposed atraumatic first and second open ends with each open end having a circumference; wherein the first and second wires ends are disposed at the second stent open end and the wires are looped at the second stent open end so that none of the first or second wires ends are exposed at the circumference of second stent open end; wherein at least of two of the wires are formed into a repositioning and/or retrieval loop having an elongated portion circumferentially disposed at the first opposed open end; and wherein the reposition and/or retrieval loop includes two sections which run adjacent to each other prior to crossing; wherein both sections the reposition and/or retrieval loop may be simultaneously accessed or grabbed to reposition and/or
- the present invention provides at least one retrieval and/or repositioning loop (RRL) which is integral and formed from one of the wires which are braided to form the stent.
- the retrieval and/or repositioning loop retrieval and/or repositioning loop is designed to provide a structure which has the required tensile strength to prevent fracture or damage to the stent when force is applied to reposition or retrieve the stent, yet allows for a very low delivery profile such that it can easily be loaded onto a delivery device without interfering with the deployment into the body or requiring increased deployment force.
- retrieval and/or repositioning loop retrieval and/or repositioning loop is part of the actual braided stent structure per se , as opposed to being a separate add-on element, no joining, i.e., welding, crimping or twisting, of the retrieval and/or repositioning loop retrieval and/or repositioning loop to the braided stent structure is necessary. Tensile strength of the retrieval and/or repositioning loop may thus be maximized while concomitantly maintaining the lowest profile for delivery to a patient.
- the wire or wires used to form at least one retrieval and/or repositioning loop may be of the same type and material as the other wires forming the braided stent, or alternatively they may be made from different types or materials.
- the retrieval and/or repositioning loop is made from wire which is the same material and diameter, i.e., outside diameter (OD), as other wires which form the braided stent.
- the retrieval and/or repositioning loop can further seamlessly transition into the body of the stent
- the phrase "retrieval and/or repositioning loop” refers to a retrieval loop, a repositioning loop, or a combination thereof which is integrally formed with a stent and, when a longitudinally pulling force is applied thereto, aids in the radial contraction or cinching of the stent to facilitate movement, repositioning and/or retrieval of the stent.
- More than one retrieval and/or repositioning loop may be incorporated into the stent.
- each stent end might have one or more retrieval and/or repositioning loops.
- only one retrieval and/or repositioning loop is present at one or more ends.
- FIG. 1 depicts stent 10 of the present invention.
- Stent 10 is a hollow tubular structure having opposed first and second open ends 12 , 14 and having a tubular wall 16 therebetween.
- a portion of the tubular wall 16 is depicted in FIG. 2 as having a plurality of elongate wires 18 formed into the tubular wall 16 .
- the elongate wires 18 traverse the length of the stent 10 in a direction traverse to the longitudinal length of the stent 10 .
- the elongate wires 18 may be formed into the tubular wall 16 by braiding the wires 18 , winding the wires 18 , knitting the wires 18 , and combinations thereof.
- the wires 18 are braided in a braided pattern 20 to form the tubular wall 16 .
- a useful nonlimiting braided pattern includes a one over and one under pattern, but other patterns may suitably be used.
- stent 10 is desirably an atraumatic stent having no sharp terminating members at one or both of the opposed first and second open ends 12 , 14 .
- the elongate wires 18 terminating at open end 12 are mated to form closed loops 22 and adjacently mated wires are secured to one and the other by mechanical means, such as welds 26 .
- the positioning of adjacently mated wires to form closed-loop end designs is further described in U.S. Published application No. US 2005-0049682 A1 , and U.S. Provisional Application No.
- the elongate wires 18 terminating at open end 12 are in a cathedral type arch or loop configuration. Further details of the cathedral type of arch or closed-loop configuration may be found in U.S. Application No. 10/845,844, filed May 15, 2004 , the contents of which are incorporated herein by reference.
- the stent wires 18 at the open end 14 are bent to form closed loop ends 24 thereat.
- the loop ends 24 are substantially angular having approximately or about a 90° bend.
- the radius of curvature at the point of the bend is desirably minimized.
- the loop ends 24 desirably have an angularly bent portion between substantially straight wire portions that do not otherwise have a portion with a significant radius of curvature.
- the loop ends 24 are not limited to angular bends of 90° and other bend angles may suitably be used.
- angular bends with a bend angle from about 30° to about 150° are also useful.
- Other useful bend angles include from about 60° to about 120°, from about 70° to about 110°, from about 80° to about 100°, from about 85° to about 95°, and the like.
- the stent 10 depicted in FIG. 3 includes multiple wires, such as 24 wires 18 as depicted in FIG. 3 , of nitinol or nitinol-containing material.
- the wires are relatively thin at a diameter of about 0.011 inches.
- the number of wires and the diameters of the wires, which may be the same or different, depicted in FIG. 3 are not limiting, and other numbers of wires and other wire diameters may suitably be used. Desirably, an even number of wires are used, for example from about 10 to about 36 wires.
- the wires 18 are made from any suitable implantable material, including without limitation nitinol, stainless steel, cobalt-based alloy such as Elgiloy®, platinum, gold, titanium, tantalum, niobium, polymeric materials and combinations thereof.
- suitable implantable material including without limitation nitinol, stainless steel, cobalt-based alloy such as Elgiloy®, platinum, gold, titanium, tantalum, niobium, polymeric materials and combinations thereof.
- polymeric stent materials include poly(L-lactide) (PLLA), poly(D,L-lactide) (PLA), poly(glycolide) (PGA), poly(L-lactide-co-D,L-lactide) (PLLA/PLA), poly(L-lactide-co-glycolidc) (PLLA/PGA), poly(D,L-lactide-co-glycolide) (PLA/PGA), poly(glycolide-co-trimethylene carbonate) (PGA/PTMC), polydioxanone (PDS), Polycaprolactone (PCL), polyhydroxybutyrate (PHBT), poly(phosphazene) poly(D,L-lactide-co-caprolactone) PLA/PCL), poly(glycolide-co-caprolactone) (PGA/PCL), poly(phosphate ester) and the like.
- PLLA poly(L-lactide)
- PLA poly(D,L-lactide)
- PGA
- Wires made from polymeric materials may be also include radiopaque materials, such as metallic-based powders, particulates or pastes which may be incorporated into the polymeric material.
- the radiopaque material may be blended with the polymer composition from which the polymeric wire is formed, and subsequently fashioned into the stent as described herein.
- the radiopaque material may be applied to the surface of the metal or polymer stent.
- various radiopaque materials and their salts and derivatives may be used including, without limitation, bismuth, barium and its salts such as barium sulphate, tantulaum, tungsten, gold, platinum and titanium, to name a few. Additional useful radiopaque materials may be found in U.S. Patent No.
- the stent may be selectively made radiopaque at desired areas along the wire or made be fully radiopaque, depending on the desired end-product and application.
- the wires 18 have an inner core of tantalum, gold, platinum, iridium or combination of thereof and an outer member or layer of nitinol to provide a composite wire for improved radiocapicity or visibility.
- the inner core is platinum and the outer layer is nitinol. More desirably, the inner core of platinum represents about at least 10% of the wire based on the overall cross-sectional percentage.
- nitinol that has not been treated for shape memory such as by heating, shaping and cooling the nitinol at its martensitic and austenitic phases, is also useful as the outer layer. Further details of such composite wires may be found in U.S. Patent Application Publication 2002/0035396 A1 , the contents of which is incorporated herein by reference.
- the wires 18 are made from nitinol, or a composite wire having a central core of platinum and an outer layer of nitinol.
- the filling weld material if required by welding processes such as MIG, may also be made from nitinol, stainless steel, cobalt-based alloy such as Elgiloy, platinum, gold, titanium, tantalum, niobium, and combinations thereof preferably nitinol.
- the material of the cathode is no critical and can be made out of any suitable metal.
- the filling weld material and the wire 18 may be made of the same material, for example nitinol.
- the wires 18 may have a composite construction, such as described found in U.S. Patent Application Publication 2002/0035396 A1 , the contents of which is incorporated herein by reference.
- the wires 18 may have an inner core of tantalum gold, platinum, iridium or combination of thereof and an outer member or layer of nitinol to provide a composite wire for improved radiocapicity or visibility.
- the wires 18 are made from nitinol.
- Either of both of the opposed open ends 12 , 14 of the stent 10 may have a retrieval and/or repositioning loop thereat.
- the retrieval and/or repositioning loop is useful for repositioning and/or retrieval of an implanted or deployed stent 10 .
- the retrieval and/or repositioning loop allows a practitioner to contract and move, reposition and/or retrieve the stent 10 within an implanted lumen (not shown).
- the stent retrieval member may be made from a memory shape alloy, such as the above described materials, including nitinol.
- the use of a shape memory material, as compared other convention materials such as suture thread, has numerous advantages.
- the self-supporting nature of the shape memory material facilitates the locating of the retrieval and/or repositioning loop.
- a memory shape alloy member will not tangle, a potential problem with suture loops, especially with suture loops made from natural or polymeric threads or filaments, and will also aid in opening the stent 10 .
- Another advantage from using a memory shape alloy material is the wire loop defining the retrieval and/or repositioning loop would be less likely to break than a plastic or polymeric loop when a pulling force is applied, such as required for repositioning or removal of the stent 10 .
- the stent 10 includes the retrieval and/or repositioning loop 28 .
- the retrieval and/or repositioning loop 28 includes a first section 30 having a stent wire 32 that is substantially circumferentially disposed the end 14 of stent 10 .
- the retrieval and/or repositioning loop 28 includes a second section 34 having a circumferential portion that only partially traverses the circumference of the end 14 of stent 10 .
- the retrieval and/or repositioning loop second section 34 includes two legs 36 , 38 that emerge from the braid 20 of the stent 10 . In other words, the base 40 of the legs 36 , 38 are contained within the braided pattern 20 of the stent 10 .
- the wire 32 forming the first section 30 of the retrieval and/or repositioning loop 28 is also desirably part of the braid pattern 20 of the stent 10 .
- the wire 32 after forming the first section 30 of the retrieval and/or repositioning loop 28 , enters into the normal braiding pattern 20 of the stent 10 .
- the apex 42 of the legs 36 , 38 is angularly bent thereby forming a top portion 44 having a length that partially circumvents the circumference of the stent end 14 .
- the top portion 44 is provided with a circumferential length to permit easy access by a practitioner of the retrieval and/or repositioning loop 28 .
- first section 30 and the second section 34 of the retrieval and/or repositioning loop 28 are accessed and pulled, such as by portion 46 of the retrieval and/or repositioning loop 28 where in first section 30 and the second section 34 are juxtaposingly disposed to one and another, the stent end 14 is axially compressed or radially contracted by a cinching action of the circumferential portion of the wire 32 .
- a portion 34 may also be referred to as a grabbing area or portion 34 as it is configured for easy access by a practitioner, for example a practitioner using forceps (not shown).
- wires forming both the first and section sections 30 , 34 are integral with the braid pattern 20 of the stent 10 , such integral wires further facilitate movement, repositioning or retrieval of the stent 10 by, among other things, providing a cinching or radially contracting action along the longitudinal length of the stent and also by transferring the pulling force along the longitudinal length of the stent
- the pulling of the retrieval and/or repositioning loop 28 provides for simultaneous contracting and pulling of the stent 10 .
- a pulling force is applied to an end of a stent without having a retrieval and/or repositioning loop 28 , there is no cinching or radial contracting force generated at that stent end.
- FIG. 5 depicts a partial front view of the stent 10 having the retrieval and/or repositioning loop 28 of the present invention.
- the stent wires 18 on the front face of the stent 10 are depicted, but the stent wires 18 on the back face are not shown for simplicity and for better illustration of the retrieval and/or repositioning loop 28 of the present invention.
- FIG. 6 depicts a side view of the stent 10 having the retrieval and/or repositioning loop 28 .
- FIG. 7 depicts a back view of the stent 10 having the retrieval and/or repositioning loop 28 . As depicted in FIGS.
- the retrieval and/or repositioning loop 28 desirably extends longitudinally outward from the braided portions forming the remaining portion of the stent end 14 .
- Such extended and elongated retrieval and/or repositioning loop 100 facilitates grabbing of the retrieval and/or repositioning loop 100 by a practitioner.
- the wire 32 forming the first section 102 of the retrieval and/or repositioning loop 100 may cross over the wire the wire forming the second section 104 .
- Such a encompassing of the circumferential perimeter of the stent end 14 facilitates access by a practitioner and also facilitates in a cinching action of the stent end 14 when a longitudinal pulling force is applied to the retrieval and/or repositioning loop 28 of the present invention.
- wire 32 for example wire 32
- first section 30 which completely circumscribes the circumferential perimeter of the stent end 14
- wire 32 or the first section 30 may suitably substantially circumscribe the circumferential perimeter of the stent end 14 or may suitably partially circumscribe the circumferential perimeter of the stent end 14 .
- FIG. 6 depicts a partial side view of the stent 10 having the retrieval and/or repositioning loop 28 of the present invention.
- the stent wires 18 on the front side face of the stent 10 are depicted, but the stent wires 18 on the back side face are not shown for simplicity and for better illustration of the retrieval and/or repositioning loop 28 of the present invention.
- the wire 30 extends longitudinally away or outward from the stent end 14 so that it is juxtaposingly disposed with the second section 34 at the grabbing area 46 . Such a longitudinal extent facilitates access to the retrieval and/or repositioning loop 28 of the present invention by, for example, a practitioner.
- FIG. 7 depicts a partial back view of the stent 10 having the retrieval and/or repositioning loop 28 .
- the stent wires 18 on the back face of the stent 10 are depicted, but the stent wires 18 on the front face are not shown for simplicity and for better illustration of the retrieval and/or repositioning loop 28 of the present invention.
- the stent wires 18 on the front side face of the stent 10 are depicted, but the stent wires 18 on the back side face are not shown for simplicity and for better illustration.
- the second section 34 of the retrieval and/or repositioning loop 28 has a shape of an inverted "U", i.e., the top of legs 36 , 38 are unitary with the top portion 44 of the second section 34 , while the bottom of the legs 36 , 38 are not interconnected so that when grabbing area 46 or the top portion 44 is pulled the legs 36 , 38 may move toward one and another, thereby facilitating cinching or radial contraction of the stent end 14 and of stent 10 of present invention.
- the retrieval and/or repositioning loop 28 desirably extends longitudinally outward from the braided portions forming the remaining portion of the stent end 14 .
- Such an extended and elongated retrieval and/or repositioning loop 28 facilitates grabbing of the retrieval and/or repositioning loop 28 by a practitioner.
- FIG. 8 is an expanded partial view of the wires forming the retrieval and/or repositioning loop 28 of the present invention.
- the wire 32 of first section 30 of the retrieval and/or repositioning loop 28 of the present invention may juxtaposingly cross over the wire 48 of the second portion 34 at the top portion 44 of second section 34 .
- the wires 32 , 48 may abuttingly and slidably engage one and the other in an unlocked or unsecured fashion to allow movement therebetween.
- Such a crossing of the wires 48 and 32 in a freely moving, juxtaposingly relationship advantageously permits a practitioner to grab both sections 30 , 34 to retrieve or reposition the stent 10 .
- the present invention is not so limited and the wires 32 , 48 may be secured to one and the other thereat by other means, for example suturing, welding and the like.
- the wire 32 forming the first section 30 of the retrieval and/or repositioning loop 28 may cross through some, but not all, of the angular bends 24 at stent end 14 .
- some of the angular bends 24 may be longitudinally offset from other of the angular bends 24 , and the wire 32 may suitably cross through those bends 24 at the very end of the stent 10 while no crossing through the bends 24 that are disposed inwardly from the stent end 14 .
- the angular bends 24 are longitudinally offset from one and the other, but the present invention is not so limited.
- the stent 10 may have no offsetting of the bends 24 at stent end 14 .
- the wire 32 forming the first section 30 of the retrieval and/or repositioning loop 28 may extend substantially about the circumference of the stent end 14 , which is defined by the angular bends 24 , and then have a longitudinal extent 50 jutting away from the stent end 14 .
- the top portion 52 of the longitudinal extend 50 may then cross the top portion 44 of the second section 34 (not shown) of the retrieval and/or repositioning loop 28 .
- This aspect of the retrieval and/or repositioning loop 28 of the present invention differs from the aspect depicted in FIG.
- the wire 32 traverses from one or more angular bends 24 in a diagonal fashion toward the grabbing area 46 of the retrieval and/or repositioning loop 28 .
- the present invention is not so limited, and the wire 32 , i.e. the top portion 52 , need not cross the grabbing area 46 of the second section 34 .
- the retrieval and/or repositioning loop 28 may be formed by the wire 32 and does not have to include the wire 48 .
- the retrieval and/or repositioning loop 28 of the present invention may suitably be formed from only the first section 30 where the wire 32 extends substantially about the circumference of the stent end 14.
- the first section 30 when pulled, provides a cinching or radial contraction action and a longitudinal stretching action for movement, repositioning or retrieval of the stent 10 .
- the top portion 52 of the retrieval and/or repositioning loop 28 may extend radially outward from the stent end 14 to facilitate access by a practitioner.
- the present invention is not so limited, and the top portion 52 of the retrieval and/or repositioning loop 28 may extend slightly inwardly in a radially fashion or be substantially longitudinally in line or parallel with the longitudinal wall of the stent 10 .
- Such a radially inward, radially outwardly or radially parallel configuration may also be present in the grabbing area 46 having both the first and second sections 30 , 34 of the retrieval and/or repositioning loop 28 of the present invention.
- the stent 10 easily contracts upon application of a pulling force, "P", to the retrieval and/or repositioning loop 28 .
- the retrieval and/or repositioning loop 28 of the present invention may be formed by wrapping one wire, for example wire 32 , around template pins 56 disposed on a mandrel 54 prior to braiding the stent 10 to form a perimetrical section 58 which is generally circular.
- a perimetrical section 58 desirably forms the fist section 30 of the retrieval and/or repositioning loop 28 of the present invention.
- the retrieval and/or repositioning loop 28 also then may be provided with a larger exaggerated section 60 , such as grabbing area 46 , for easy grabbing by the practitioner or physician.
- This exaggerated section 60 , 46 of the retrieval and/or repositioning loop 28 is also formed by wrapping a second wire 48 around template pins 56 positioned on the mandrel 54 to cause the desired looped shape.
- a pulling force on the retrieval and/or repositioning loop 28 will cause cinching of the braid to a smaller diameter as it lengthens axial, by thus allowing for less frictional force against the vessel wall and permitting repositioning and/or retrieval of the deployed stent
- the retrieval and/or repositioning loop wires are then braided in with the other wires, for example wires 18 , using the braiding technique as described herein.
- the retrieval and/or repositioning loop may be interlaced with one or more adjacent end loops formed from other wires as it is wrapped around the mandrel, or it need not be interlaced with any adjacent wire loops at the stent end. In the latter case, optional attachment methods such as sutures or clamps may be used to attach the retrieval and/or repositioning loop to one or more adjacent end loops of the stent. Having the retrieval and/or repositioning loop interlace with one or more, and desirably at least two adjacent end loops from the other adjacent wires is one particularly desirable embodiment.
- the retrieval and/or repositioning loop is designed to be grabbed at the area where the stent wires 30 , 48 forming the retrieval and/or repositioning loop 28 crosses themselves as shown in FIG. 8 .
- the retrieval and/or repositioning loop 28 may have an exaggerated loop or distended section 46 , 60 where it crosses itself and when grabbed at this crossing by the operator, the amount of distance the retrieval and/or repositioning loop will have to be pulled will be reduced by about one-half. In other words, pulling the retrieval and/or repositioning loop at the crossing point of itself (double pull wire), reduces the length of the pulled retrieval and/or repositioning loop by about one-half. As shown in FIG.
- the grabbing area 46 where the retrieval and/or repositioning loop wires 32 , 48 cross may be made to be as large as possible to facilitate and ensure the two sections of the retrieval and/or repositioning loop wire can be grabbed together. This may allow for enhanced endoscopic visualization of the stent
- the grabbing, area 46 is desirably sized for at least two of the wire crossings in the braid pattern of the stent.
- the grabbing area of the retrieval and/or repositioning loop can be positioned at any desired location along the wire from which it is formed prior to the wire crossing adjacent wires to begin the braid.
- the retrieval and/or repositioning loop may be a single pull wire and the pull length may be longer (approximately twice the length) than the pull length of those designed to be pulled at the section where the retrieval and/or repositioning loop crosses itself.
- the retrieval and/or repositioning loop may also have the same or different properties than other wires which form the braided stent. For example, it may be of the same or different stiffness or flexibility, all of which may be tailored for a particular application. The choice of material, wire diameter and pro-treatment of the wires and stent configuration are some of the factors which may be varied to achieve particular stent properties. Additionally, as mentioned herein, the at least one retrieval and/or repositioning loop may also be made radiopaque by various methods, for example with a coating or finish, with a band or as part of the stent material, as further described herein. Color or different finishes may also be added to the retrieval and/or repositioning loop to visually differentiate it from the rest of the stent wires.
- the grabbing area 46 includes two juxtaposed wires 32 , 148 .
- the grabbing area 46 is not so limited.
- the retrieval and/or repositioning loop 28 ' may include only the circumferential wire 32 that is subsequently interbraided to form the stent 10 . Further as depicted in FIG. 15 , the retrieval and/or repositioning loop 28 ' may include only the circumferential wire 32 that is subsequently interbraided to form the stent 10 . Further as depicted in FIG.
- the circumferential wire 32 is desirably part of the braided wires 18 used in forming the stent 10 , thereby forming the integral retrieval and/or repositioning loop 28 of the present invention.
- the stent 10 may then be braided to form a tubular structure. Stent wires 18 are disposed about pins 62 and after which braiding of the wires commence. Additional details of braiding may be found in U.S. Patent No. 6,792,979 , the contents of which are incorporated herein by reference.
- the stent 10 of the present invention may have the integral retrieval and/or repositioning loop 28 , 28 ' integrally formed at either stent 12 , 14 .
- the stent 10 of the present invention may have a coating.
- the coating is a tubular covering of silicone.
- the stent 10 may be placed on a coating mandrel (not shown) by means of a tie 64 after which the assembly is dipped into a silicone solution to form the coating.
- the retrieval and/or repositioning loop portion 28 is not silicone covered.
- the coating or covering is a silicone covering, but other coverings, particularly elastomeric polymers, are useful.
- the coating embeds the stent 10 . therein and essentially forms a stent covering.
- the mandrel may be truncated or geometrically altered such that it does not permit coating of the retrieval and/or repositioning loop, or the retrieval and/or repositioning loop can be pulled away from the mandrel during coating and formation of the polymer covering.
- one end of the stent 10 may have weld joints 68 which, due to their positioning, provide higher radial strength, i.e., the resultant stents 10 can withstand higher radial compressive forces without fear of weld failure.
- the weld joint 68 is positioned between the crossings of adjacent wires, as shown in FIGS. 19A and 19B .
- wires 18 to be welded may be disposed about islands or pins 66 on a mandrel (not shown). After the welds 68 are formed or while the welds 68 are being formed wire portions not forming the stent 10 may be cut or otherwise removed from the stent braiding pattern 20 .
- the stent 10 may be fully, substantially or partially covered or lined with a polymeric material 70 .
- the stent 10 may also be embedded in a polymeric coating.
- the covering may be in the form of a tubular structure.
- useful polymeric materials include polyesters, polypropylenes, polyethylenes, polyurethanes, polynaphthalenes, polytetrafluoroethylenes, expanded polytetrafluoroethylene, silicone, and combinations and copolymers thereof.
- the polymeric material 70 is silicone.
- the polymeric material and/or silicone 70 may be disposed on external surfaces 72 of the stent 10 , as depicted in FIG. 21 , or disposed on the internal surfaces 74 of the stent 10, as depicted in FIG. 22 , or combinations thereof.
- FIGS. 23-25 depict additional details of the stent end 14 having the retrieval and/or repositioning loop 28 .
- the wire 32 may have a substantially or partially extending circumferential portion 76 and a longitudinally extending portion 50 so that the sections 30 and 34 of the retrieval and/or repositioning loop 28 are juxtaposed or have portion that are juxtaposed with one and the other, desirably in slidably relationship which may also be an abutting relationship.
- the stent 10 may be used for a number of purposes including to maintain patency of a body lumen, vessel or conduit, such as in the coronary or peripheral vasculature, esophagus, trachea, bronchi colon, biliary tract, urinary tract, prostate, brain, and the like.
- the devices of the present invention may also be used to support a weakened body lumen or to provide a fluid-tight conduit for a body lumen.
- the stent 10 may be treated with any known or useful bioactive agent or drug including without limitation the following: anti-thrombogenic agents (such as heparin, heparin derivatives, urokinase, and PPack (dextrophenylalanine proline arginine chloromethylketone); anti-prolierative agents (such as enoxaprin, angiopeptin, or monoclonal antibodies capable of blocking smooth muscle cell proliferation, hirudin, and acetylsalicylic acid); anti-inflammatory agents (such as dexamethasone, prednisolone, corticosterone, budesonide, estrogen, sulfasalazine, and mesalamine); antineoplastic/antiproliferative/anti-miotic agents (such as paclitaxel, 5-fluorouracil, cisplatin, vinblastine, vincristine, epothilones, endostatin, angiostatin and thymidine
- the general tubular shape may be varied.
- the tubular shape may have a varied diameter, may be tapered, and may have an outwardly flared end and the like.
- the ends of the stent may have a larger diameter than the middle regions of the stent.
- at least one of the ends of the stent transition from one diameter to another diameter. Desirably, both ends transition in this manner to yield "flared" ends, as depicted in FIG. 19 .
- the stent may be coated with a polymeric material.
- the stent wires may be partially or fully covered with a biologically active material which is elutably disposed with the polymeric material.
- the polymeric coating may extend over or through the interstitial spaces between the stent wires so as to provide a hollow tubular liner or cover over the interior or the exterior surface of the stent
- the polymeric material may be selected from the group consisting of polyester, polypropylene, polyethylene, polyurethane, polynaphthalene, polytetrafluoroethylene, expanded polytetrafluoroethylene, silicone, and combinations thereof.
- stent types and stent constructions may be employed in the invention.
- various stents useful include, without limitation, self-expanding stents and balloon expandable extents.
- the stents may be capable of radially contracting, as well and in this sense can best be described as radially distensible or deformable.
- Self-expanding stents include those that have a spring-like action which causes the stent to radially expand, or stents which expand due to the memory properties of the stent material for a particular configuration at a certain temperature.
- Nitinol is one material which has the ability to perform well while both in spring-like mode, as well as in a memory mode based on temperature.
- stents can be fastened into a continuous helical pattern, with or without a wave-like or zig-zag in the wire, to form a radially deformable stent
- Individual rings or circular members can be linked together such as by struts, sutures, welding or interlacing or locking of the rings to form a tubular stent.
- Tubular stents useful in the present invention also include those formed by etching or cutting a pattern from a tube.
- stents are often referred to as slotted stents.
- stents may be formed by etching a pattern into a material or mold and depositing stent material in the pattern, such as by chemical vapor deposition or the like. Examples of various stent configurations are shown in U.S. Patent Nos. 4,503,569 to Dotter ; 4,733,665 to Palmaz ; 4,856,561 to Hillstead ; 4,580,568 to Gianturco ; 4,732,152 to Wallsten , 4,886,062 to Wiktor , and 5,876,448 to Thompson , all of whose contents are incorporated herein by reference.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Prostheses (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68068905P | 2005-05-13 | 2005-05-13 | |
EP06759623.9A EP1887974B1 (fr) | 2005-05-13 | 2006-05-11 | Stent integre presentant une boucle de repositionnement et d'extraction |
EP13180768.7A EP2666508B1 (fr) | 2005-05-13 | 2006-05-11 | Stent integre presentant une boucle de repositionnement et d'extraction |
PCT/US2006/018337 WO2006124541A2 (fr) | 2005-05-13 | 2006-05-11 | Stent integre presentant une boucle de repositionnement et d'extraction |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP06759623.9A Division EP1887974B1 (fr) | 2005-05-13 | 2006-05-11 | Stent integre presentant une boucle de repositionnement et d'extraction |
EP13180768.7A Division EP2666508B1 (fr) | 2005-05-13 | 2006-05-11 | Stent integre presentant une boucle de repositionnement et d'extraction |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3597256A1 true EP3597256A1 (fr) | 2020-01-22 |
EP3597256B1 EP3597256B1 (fr) | 2023-01-18 |
Family
ID=37000029
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP06759623.9A Active EP1887974B1 (fr) | 2005-05-13 | 2006-05-11 | Stent integre presentant une boucle de repositionnement et d'extraction |
EP13180768.7A Active EP2666508B1 (fr) | 2005-05-13 | 2006-05-11 | Stent integre presentant une boucle de repositionnement et d'extraction |
EP19185559.2A Active EP3597256B1 (fr) | 2005-05-13 | 2006-05-11 | Stent intégré présentant une boucle de repositionnement et d'extraction |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP06759623.9A Active EP1887974B1 (fr) | 2005-05-13 | 2006-05-11 | Stent integre presentant une boucle de repositionnement et d'extraction |
EP13180768.7A Active EP2666508B1 (fr) | 2005-05-13 | 2006-05-11 | Stent integre presentant une boucle de repositionnement et d'extraction |
Country Status (5)
Country | Link |
---|---|
US (6) | US9265634B2 (fr) |
EP (3) | EP1887974B1 (fr) |
JP (1) | JP5008660B2 (fr) |
ES (1) | ES2671416T3 (fr) |
WO (1) | WO2006124541A2 (fr) |
Families Citing this family (114)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7018401B1 (en) | 1999-02-01 | 2006-03-28 | Board Of Regents, The University Of Texas System | Woven intravascular devices and methods for making the same and apparatus for delivery of the same |
US20080300314A1 (en) * | 2003-11-21 | 2008-12-04 | Givaudan Sa | Cooling Compounds |
US20060206200A1 (en) * | 2004-05-25 | 2006-09-14 | Chestnut Medical Technologies, Inc. | Flexible vascular occluding device |
JP5009163B2 (ja) * | 2004-11-10 | 2012-08-22 | ボストン サイエンティフィック リミテッド | 配備に要する力を減じた外傷回避ステントと、その製造方法と、ステント搬送配備システム |
DE102005003632A1 (de) | 2005-01-20 | 2006-08-17 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Katheter für die transvaskuläre Implantation von Herzklappenprothesen |
WO2006081448A1 (fr) * | 2005-01-28 | 2006-08-03 | Boston Scientific Limited | Element de reperage de tuteur intravasculaire, dispositifs et procedes de reperage ou de repositionnement de tuteur intravasculaire |
ES2671416T3 (es) * | 2005-05-13 | 2018-06-06 | Boston Scientific Limited | Stent integrado que presenta un bucle de reposicionamiento y / o recuperación |
EP1988851A2 (fr) * | 2006-02-14 | 2008-11-12 | Sadra Medical, Inc. | Systemes et procedes pour installer un implant medical |
US8535368B2 (en) | 2006-05-19 | 2013-09-17 | Boston Scientific Scimed, Inc. | Apparatus for loading and delivering a stent |
CN102836023B (zh) * | 2006-10-18 | 2015-12-02 | 印斯拜尔Md有限公司 | 编织的支架套 |
EP3150177B1 (fr) | 2006-10-22 | 2021-06-02 | Idev Technologies, Inc. | Procédés de fixation d'extrémités de brins et dispositifs résultants |
US7896915B2 (en) | 2007-04-13 | 2011-03-01 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
US8187284B2 (en) | 2007-04-23 | 2012-05-29 | Boston Scientific Scimed, Inc. | Intraluminary stent relocating apparatus |
US9034007B2 (en) | 2007-09-21 | 2015-05-19 | Insera Therapeutics, Inc. | Distal embolic protection devices with a variable thickness microguidewire and methods for their use |
US9393137B2 (en) * | 2007-09-24 | 2016-07-19 | Boston Scientific Scimed, Inc. | Method for loading a stent into a delivery system |
CZ303081B6 (cs) * | 2007-12-13 | 2012-03-21 | Ella-Cs, S. R. O. | Zpusob výroby samoexpanzního biodegradabilního stentu |
US8623071B2 (en) * | 2008-01-07 | 2014-01-07 | DePuy Synthes Products, LLC | Radiopaque super-elastic intravascular stent |
ES2903231T3 (es) | 2008-02-26 | 2022-03-31 | Jenavalve Tech Inc | Stent para el posicionamiento y anclaje de una prótesis valvular en un sitio de implantación en el corazón de un paciente |
US9044318B2 (en) | 2008-02-26 | 2015-06-02 | Jenavalve Technology Gmbh | Stent for the positioning and anchoring of a valvular prosthesis |
AT506842B1 (de) * | 2008-06-12 | 2010-03-15 | Michaela Dr Abrahamowicz | Gerät zur diagnostik eines inneren rektum-prolapses sowie einer beckenboden-senkung und zur bestimmung der douglas-tiefe |
DE102008002641A1 (de) * | 2008-06-25 | 2009-12-31 | Biotronik Vi Patent Ag | Faserstrang und implantierbarer Stützkörper mit einem Faserstrang |
DE102008033170A1 (de) | 2008-07-15 | 2010-01-21 | Acandis Gmbh & Co. Kg | Implantat mit einer geflochtenen Gitterstruktur und Verfahren zum Herstellen eines derartigen Implantats |
DE102008036429A1 (de) | 2008-08-05 | 2010-02-11 | Acandis Gmbh & Co. Kg | Medizinisches Implantat |
WO2010091383A2 (fr) * | 2009-02-09 | 2010-08-12 | St. Jude Medical | Système gonflable minimalement invasif pour la mise en place et la fixation d'un implant annulaire |
GB0903247D0 (en) * | 2009-02-26 | 2009-04-08 | Depuy Int Ltd | Support structure implant for a bone cavity |
KR20100119068A (ko) * | 2009-04-30 | 2010-11-09 | (주) 태웅메디칼 | 스텐트 제거용 당김줄의 걸고리 구조 |
WO2011002996A2 (fr) * | 2009-07-02 | 2011-01-06 | The Cleveland Clinic Foundation | Appareil et procédé de remplacement d'une valvule cardiaque malade |
CA2771120C (fr) * | 2009-09-10 | 2017-07-11 | Boston Scientific Scimed, Inc. | Endoprothese avec repositionnement de filament ou element de recuperation et structure protectrice |
CA2773315A1 (fr) * | 2009-09-21 | 2011-03-24 | Boston Scientific Scimed, Inc. | Boucle de recuperation d'endoprothese integree pour enlevement a l'anse et/ou cordage de bourse optimise |
WO2011044486A1 (fr) | 2009-10-09 | 2011-04-14 | Boston Scientific Scimed, Inc. | Dérivation gastrique pour le traitement de l'obésité |
KR101109708B1 (ko) * | 2009-10-27 | 2012-01-31 | (주) 태웅메디칼 | 전립선 요도 확장용 스텐트 |
AU2011210720B2 (en) * | 2010-01-29 | 2014-07-24 | Cook Medical Technologies LLC. | Collapsing structure for reducing the diameter of a stent |
US8632582B2 (en) | 2010-03-25 | 2014-01-21 | Mayo Foundation For Medical Education And Research | Removable and/or retrievable stents and kits |
WO2011137043A1 (fr) * | 2010-04-30 | 2011-11-03 | Boston Scientific Scimed, Inc. | Appareil et procédé de fabrication d'une endoprothèse à fil unique |
KR101160646B1 (ko) * | 2010-05-14 | 2012-06-29 | 신경민 | 위 절제 후 음식물 의한 부작용 방지 전용 스텐트 |
JP2013526388A (ja) | 2010-05-25 | 2013-06-24 | イエナバルブ テクノロジー インク | 人工心臓弁、及び人工心臓弁とステントを備える経カテーテル搬送体内プロテーゼ |
JP5801037B2 (ja) * | 2010-05-25 | 2015-10-28 | アクセスポイント テクノロジーズ有限会社 | ステント |
US9084681B2 (en) * | 2010-06-18 | 2015-07-21 | DePuy Synthes Products, Inc. | Spine disc replacement with compliant articulating core |
DE102010027123A1 (de) * | 2010-07-14 | 2012-01-19 | Acandis Gmbh & Co. Kg | Medizinische Vorrichtung |
JP6055163B2 (ja) * | 2010-07-27 | 2016-12-27 | アクセスポイント テクノロジーズ有限会社 | ステント |
DE102010044746A1 (de) * | 2010-09-08 | 2012-03-08 | Phenox Gmbh | Implantat zur Beeinflussung des Blutflusses bei arteriovenösen Fehlbildungen |
US8945207B2 (en) | 2010-12-20 | 2015-02-03 | Graftcraft I Göteborg Ab | Removable stent and method of production |
CA2820405C (fr) | 2010-12-20 | 2017-10-24 | Graftcraft I Goteborg Ab | Stent amovible et procede de fabrication |
JP2013019347A (ja) * | 2011-07-12 | 2013-01-31 | Nihon Glassfiber Industrial Co Ltd | 金属線圧縮体 |
WO2013028592A1 (fr) | 2011-08-22 | 2013-02-28 | Cook Medical Technologies Llc | Système d'endoprothèse pouvant être de nouveau contrainte |
JP6346861B2 (ja) * | 2012-04-06 | 2018-06-20 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | 内部人工器官およびその製造方法 |
US8882828B2 (en) * | 2012-04-27 | 2014-11-11 | Medtronic Vascular, Inc. | Ring on a closed web stent-graft for use in tip capture |
EP2895211B1 (fr) | 2012-09-12 | 2017-10-18 | Boston Scientific Scimed, Inc. | Revêtement adhésif anti-migration pour endoprothèse vasculaire |
US20140121747A1 (en) | 2012-10-25 | 2014-05-01 | Boston Scientific Scimed, Inc. | Stent having a tacky silicone coating to prevent stent migration |
WO2014134348A1 (fr) * | 2013-02-28 | 2014-09-04 | Boston Scientific Scimed, Inc. | Endoprothèse avec ballonnet pour la réparation de fuites chirurgicales d'anastomose |
US20140257362A1 (en) * | 2013-03-07 | 2014-09-11 | St. Jude Medical, Cardiology Division, Inc. | Filtering and removing particulates from bloodstream |
US9265635B2 (en) | 2013-03-14 | 2016-02-23 | Boston Scientific Scimed, Inc. | Stent having removable anchoring element |
US8679150B1 (en) | 2013-03-15 | 2014-03-25 | Insera Therapeutics, Inc. | Shape-set textile structure based mechanical thrombectomy methods |
WO2014150130A1 (fr) * | 2013-03-15 | 2014-09-25 | Merit Medical Systems, Inc. | Endoprothèse œsophagienne |
CN109730806B (zh) | 2013-03-15 | 2023-01-24 | 伊瑟拉医疗公司 | 脉管治疗装置和方法 |
US8715315B1 (en) | 2013-03-15 | 2014-05-06 | Insera Therapeutics, Inc. | Vascular treatment systems |
US8715314B1 (en) | 2013-03-15 | 2014-05-06 | Insera Therapeutics, Inc. | Vascular treatment measurement methods |
CN105636616A (zh) | 2013-08-08 | 2016-06-01 | 波士顿科学国际有限公司 | 防止支架移位的可溶性或可降解粘合剂聚合物 |
JP6563394B2 (ja) | 2013-08-30 | 2019-08-21 | イェーナヴァルヴ テクノロジー インコーポレイテッド | 人工弁のための径方向に折り畳み自在のフレーム及び当該フレームを製造するための方法 |
US9642944B2 (en) | 2014-03-17 | 2017-05-09 | Boston Scientific Scimed, Inc. | Platelet-activated bioadhesive stent coating as an antimigration mechanism |
CN110495968A (zh) * | 2014-06-18 | 2019-11-26 | 波士顿科学国际有限公司 | 胆道支架 |
JP6423541B2 (ja) | 2015-01-16 | 2018-11-14 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | 移動抑制能を備える埋込式医療装置 |
KR101696810B1 (ko) * | 2015-02-04 | 2017-02-01 | 주식회사 엠아이텍 | 연결용 스텐트 및 그의 제조방법 |
KR101728319B1 (ko) * | 2015-04-15 | 2017-04-19 | 주식회사 엠아이텍 | 스텐트 제조방법 |
EP4403138A3 (fr) | 2015-05-01 | 2024-10-09 | JenaValve Technology, Inc. | Dispositif et procédé avec fréquence de stimulateur cardiaque réduite lors du remplacement de valvule cardiaque |
BR102015011376B1 (pt) | 2015-05-18 | 2023-04-04 | Murilo Pundek Rocha | Brônquio artificial implantável |
USD784267S1 (en) * | 2015-08-17 | 2017-04-18 | Tessco Communications Incorporated | Cable braiding and strain relief |
WO2017031065A1 (fr) * | 2015-08-17 | 2017-02-23 | Boston Scientific Scimed, Inc. | Endoprothèse vasculaire radioactive |
US10004617B2 (en) | 2015-10-20 | 2018-06-26 | Cook Medical Technologies Llc | Woven stent device and manufacturing method |
CN108697423A (zh) | 2016-02-16 | 2018-10-23 | 伊瑟拉医疗公司 | 抽吸装置和锚定的分流装置 |
US10426592B2 (en) | 2016-04-11 | 2019-10-01 | Boston Scientific Scimed, Inc. | Implantable medical device with reduced migration capabilities |
US10390944B2 (en) * | 2016-04-13 | 2019-08-27 | Hlt, Inc. | Braided support structure |
US10568754B2 (en) | 2016-05-13 | 2020-02-25 | Boston Scientific Scimed, Inc. | Protective apparatus for use in gastrointestinal tract |
CN109475419B (zh) | 2016-05-13 | 2021-11-09 | 耶拿阀门科技股份有限公司 | 用于通过引导鞘和装载系统来递送心脏瓣膜假体的心脏瓣膜假体递送系统和方法 |
US10470904B2 (en) | 2016-05-18 | 2019-11-12 | Boston Scientific Scimed, Inc. | Stent retrieval system |
WO2018052844A1 (fr) * | 2016-09-19 | 2018-03-22 | Boston Scientific Scimed, Inc. | Système, dispositif et méthode de traitement d'endométriose |
DE102016013721A1 (de) * | 2016-11-17 | 2018-05-17 | Grammer Ag | Feder, Verwendung eines Kunststoffschlauchs als Feder und Ausstattungsteil eines Fahrzeuginnenraums |
US11197754B2 (en) | 2017-01-27 | 2021-12-14 | Jenavalve Technology, Inc. | Heart valve mimicry |
EP3700474B1 (fr) | 2017-10-25 | 2023-08-23 | Boston Scientific Scimed, Inc. | Stent avec espaceur atraumatique |
JP7290387B2 (ja) * | 2017-12-06 | 2023-06-13 | バタフライ メディカル リミテッド | 抜き出しハンドル及び/又はアーチ部材を備える泌尿器科インプラント |
EP4364703A3 (fr) | 2018-02-20 | 2024-07-31 | Boston Scientific Scimed, Inc. | Dispositif de drainage |
US12076226B2 (en) | 2018-03-19 | 2024-09-03 | Butterfly Medical Ltd. | Urological implant having extraction handle and/or arched members |
ES2725273B2 (es) * | 2018-03-20 | 2020-01-23 | Univ Zaragoza | Protesis intraluminal extraible, apta para el tratamiento de la traqueomalacia |
CA3094404A1 (fr) * | 2018-03-20 | 2019-09-26 | National Research Council Of Canada | Procede de lyophilisation de souches vaccinales vivante contre francisella tularensis |
WO2019195860A2 (fr) | 2018-04-04 | 2019-10-10 | Vdyne, Llc | Dispositifs et procédés d'ancrage d'une valvule cardiaque transcathéter |
DE102018207575A1 (de) | 2018-05-16 | 2019-11-21 | Kardion Gmbh | Magnetische Stirndreh-Kupplung zur Übertragung von Drehmomenten |
DE102018208541A1 (de) | 2018-05-30 | 2019-12-05 | Kardion Gmbh | Axialpumpe für ein Herzunterstützungssystem und Verfahren zum Herstellen einer Axialpumpe für ein Herzunterstützungssystem |
EP4275652A3 (fr) * | 2018-06-04 | 2024-01-24 | Boston Scientific Scimed, Inc. | Stent amovible |
WO2020049734A1 (fr) * | 2018-09-07 | 2020-03-12 | オリンパス株式会社 | Endoprothèse |
US11071627B2 (en) | 2018-10-18 | 2021-07-27 | Vdyne, Inc. | Orthogonally delivered transcatheter heart valve frame for valve in valve prosthesis |
US11278437B2 (en) | 2018-12-08 | 2022-03-22 | Vdyne, Inc. | Compression capable annular frames for side delivery of transcatheter heart valve replacement |
US11344413B2 (en) | 2018-09-20 | 2022-05-31 | Vdyne, Inc. | Transcatheter deliverable prosthetic heart valves and methods of delivery |
US10321995B1 (en) | 2018-09-20 | 2019-06-18 | Vdyne, Llc | Orthogonally delivered transcatheter heart valve replacement |
CN113164271A (zh) | 2018-09-24 | 2021-07-23 | 波士顿科学国际有限公司 | 可重新定位且可移除的支架 |
US11109969B2 (en) * | 2018-10-22 | 2021-09-07 | Vdyne, Inc. | Guidewire delivery of transcatheter heart valve |
CN113329716A (zh) * | 2018-11-16 | 2021-08-31 | 微仙美国有限公司 | 不透射线的血管假体 |
BR112021008489A2 (pt) * | 2018-11-19 | 2021-08-03 | Pulmair Medical, Inc. | brônquio artificial implantável, e, métodos para promover desinsuflação pulmonar e para entregar brônquio artificial implantável em uma passagem de ar . |
JP7494444B2 (ja) * | 2018-12-14 | 2024-06-04 | 住友ベークライト株式会社 | アンカーステント |
US11253359B2 (en) | 2018-12-20 | 2022-02-22 | Vdyne, Inc. | Proximal tab for side-delivered transcatheter heart valves and methods of delivery |
US11273032B2 (en) | 2019-01-26 | 2022-03-15 | Vdyne, Inc. | Collapsible inner flow control component for side-deliverable transcatheter heart valve prosthesis |
US11185409B2 (en) | 2019-01-26 | 2021-11-30 | Vdyne, Inc. | Collapsible inner flow control component for side-delivered transcatheter heart valve prosthesis |
EP3934583B1 (fr) | 2019-03-05 | 2023-12-13 | Vdyne, Inc. | Dispositifs de régulation de régurgitation tricuspide pour prothèse de valvule cardiaque transcathéter orthogonale |
US11173027B2 (en) | 2019-03-14 | 2021-11-16 | Vdyne, Inc. | Side-deliverable transcatheter prosthetic valves and methods for delivering and anchoring the same |
US11076956B2 (en) | 2019-03-14 | 2021-08-03 | Vdyne, Inc. | Proximal, distal, and anterior anchoring tabs for side-delivered transcatheter mitral valve prosthesis |
WO2020222364A1 (fr) * | 2019-04-29 | 2020-11-05 | 주식회사 에스앤지바이오텍 | Endoprothèse amovible comprenant une boucle et un élément de traction permettant de retirer une endoprothèse |
EP3965701A4 (fr) | 2019-05-04 | 2023-02-15 | Vdyne, Inc. | Dispositif cinch et procédé de déploiement d'une valvule cardiaque prothétique à pose latérale dans un anneau natif |
US11419741B2 (en) | 2019-06-17 | 2022-08-23 | Boston Scientific Scimed, Inc. | Covered endoprosthesis with improved branch access |
AU2020334080A1 (en) | 2019-08-20 | 2022-03-24 | Vdyne, Inc. | Delivery and retrieval devices and methods for side-deliverable transcatheter prosthetic valves |
CA3152632A1 (fr) | 2019-08-26 | 2021-03-04 | Vdyne, Inc. | Valvules prothetiques transcatheter a pose laterale et procedes pour leurs pose et ancrage |
USD902407S1 (en) * | 2019-11-19 | 2020-11-17 | Pulmair Medical, Inc. | Implantable artificial bronchus |
US11234813B2 (en) | 2020-01-17 | 2022-02-01 | Vdyne, Inc. | Ventricular stability elements for side-deliverable prosthetic heart valves and methods of delivery |
USD954953S1 (en) | 2020-11-03 | 2022-06-14 | Pulmair Medical, Inc. | Implantable artificial bronchus |
CN112618105B (zh) * | 2020-12-31 | 2024-04-12 | 上海翰凌医疗器械有限公司 | 一种瓣膜支架、具有瓣膜支架与输送机构的配合装置 |
USD1014758S1 (en) | 2023-04-19 | 2024-02-13 | Pulmair Medical, Inc. | Implantable artificial bronchus |
Citations (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4503569A (en) | 1983-03-03 | 1985-03-12 | Dotter Charles T | Transluminally placed expandable graft prosthesis |
US4580568A (en) | 1984-10-01 | 1986-04-08 | Cook, Incorporated | Percutaneous endovascular stent and method for insertion thereof |
US4732152A (en) | 1984-12-05 | 1988-03-22 | Medinvent S.A. | Device for implantation and a method of implantation in a vessel using such device |
US4733665A (en) | 1985-11-07 | 1988-03-29 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
US4856561A (en) | 1987-11-10 | 1989-08-15 | Hydro Conduit Corporation | Seal construction for bell and spigot pipe |
US4886062A (en) | 1987-10-19 | 1989-12-12 | Medtronic, Inc. | Intravascular radially expandable stent and method of implant |
WO1993019803A1 (fr) * | 1992-03-31 | 1993-10-14 | Boston Scientific Corporation | Fil medical |
US5643277A (en) | 1990-07-09 | 1997-07-01 | Wilson-Cook Medical, Inc. | Device for retrieving stents |
US5876448A (en) | 1992-05-08 | 1999-03-02 | Schneider (Usa) Inc. | Esophageal stent |
US20020035396A1 (en) | 1992-03-31 | 2002-03-21 | Boston Scientific Corporation, A Delaware Corporation | Tubular medical endoprostheses |
US20020143387A1 (en) * | 2001-03-27 | 2002-10-03 | Soetikno Roy M. | Stent repositioning and removal |
US20020188344A1 (en) | 2001-06-01 | 2002-12-12 | American Medical Systems | Retrievable stent and method of use thereof |
US20030040772A1 (en) * | 1999-02-01 | 2003-02-27 | Hideki Hyodoh | Delivery devices |
US6626936B2 (en) | 1997-08-01 | 2003-09-30 | Boston Scientific Scimed, Inc. | Bioabsorbable marker having radiopaque constituents |
US6676692B2 (en) | 2001-04-27 | 2004-01-13 | Intek Technology L.L.C. | Apparatus for delivering, repositioning and/or retrieving self-expanding stents |
WO2004105647A1 (fr) * | 2003-05-23 | 2004-12-09 | Scimed Life Systems, Inc. | Stents a extremites en boucle attachees |
WO2005110286A1 (fr) * | 2004-05-14 | 2005-11-24 | Boston Scientific Limited | Méthode de réduction des profils de soudure des stents; stent muni de profils de soudure réduits et configuration d’un câble fermé |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4856516A (en) * | 1989-01-09 | 1989-08-15 | Cordis Corporation | Endovascular stent apparatus and method |
US6336938B1 (en) * | 1992-08-06 | 2002-01-08 | William Cook Europe A/S | Implantable self expanding prosthetic device |
RU2089131C1 (ru) * | 1993-12-28 | 1997-09-10 | Сергей Апполонович Пульнев | Стент |
US6340367B1 (en) * | 1997-08-01 | 2002-01-22 | Boston Scientific Scimed, Inc. | Radiopaque markers and methods of using the same |
US6264689B1 (en) * | 1998-03-31 | 2001-07-24 | Scimed Life Systems, Incorporated | Low profile medical stent |
US6656218B1 (en) * | 1998-07-24 | 2003-12-02 | Micrus Corporation | Intravascular flow modifier and reinforcement device |
US6398803B1 (en) * | 1999-02-02 | 2002-06-04 | Impra, Inc., A Subsidiary Of C.R. Bard, Inc. | Partial encapsulation of stents |
DE10118944B4 (de) | 2001-04-18 | 2013-01-31 | Merit Medical Systems, Inc. | Entfernbare, im wesentlichen zylindrische Implantate |
US7001425B2 (en) * | 2002-11-15 | 2006-02-21 | Scimed Life Systems, Inc. | Braided stent method for its manufacture |
US20040225349A1 (en) * | 2003-05-09 | 2004-11-11 | Thistle Robert C. | Eversible locking mechanism for modular stents |
US8337543B2 (en) * | 2004-11-05 | 2012-12-25 | Boston Scientific Scimed, Inc. | Prosthesis anchoring and deploying device |
JP5009163B2 (ja) * | 2004-11-10 | 2012-08-22 | ボストン サイエンティフィック リミテッド | 配備に要する力を減じた外傷回避ステントと、その製造方法と、ステント搬送配備システム |
ES2671416T3 (es) * | 2005-05-13 | 2018-06-06 | Boston Scientific Limited | Stent integrado que presenta un bucle de reposicionamiento y / o recuperación |
-
2006
- 2006-05-11 ES ES06759623.9T patent/ES2671416T3/es active Active
- 2006-05-11 WO PCT/US2006/018337 patent/WO2006124541A2/fr active Application Filing
- 2006-05-11 EP EP06759623.9A patent/EP1887974B1/fr active Active
- 2006-05-11 US US11/432,065 patent/US9265634B2/en active Active
- 2006-05-11 EP EP13180768.7A patent/EP2666508B1/fr active Active
- 2006-05-11 EP EP19185559.2A patent/EP3597256B1/fr active Active
- 2006-05-11 JP JP2008511381A patent/JP5008660B2/ja active Active
-
2016
- 2016-01-18 US US14/997,984 patent/US10111766B2/en active Active
- 2016-02-26 US US15/055,527 patent/US10149776B2/en active Active
-
2018
- 2018-10-03 US US16/150,885 patent/US11013624B2/en active Active
-
2021
- 2021-05-03 US US17/306,082 patent/US11786386B2/en active Active
-
2023
- 2023-09-06 US US18/462,185 patent/US20230404782A1/en active Pending
Patent Citations (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4503569A (en) | 1983-03-03 | 1985-03-12 | Dotter Charles T | Transluminally placed expandable graft prosthesis |
US4580568A (en) | 1984-10-01 | 1986-04-08 | Cook, Incorporated | Percutaneous endovascular stent and method for insertion thereof |
US4732152A (en) | 1984-12-05 | 1988-03-22 | Medinvent S.A. | Device for implantation and a method of implantation in a vessel using such device |
US4733665B1 (en) | 1985-11-07 | 1994-01-11 | Expandable Grafts Partnership | Expandable intraluminal graft,and method and apparatus for implanting an expandable intraluminal graft |
US4733665A (en) | 1985-11-07 | 1988-03-29 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
US4733665C2 (en) | 1985-11-07 | 2002-01-29 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
US4886062A (en) | 1987-10-19 | 1989-12-12 | Medtronic, Inc. | Intravascular radially expandable stent and method of implant |
US4856561A (en) | 1987-11-10 | 1989-08-15 | Hydro Conduit Corporation | Seal construction for bell and spigot pipe |
US5643277A (en) | 1990-07-09 | 1997-07-01 | Wilson-Cook Medical, Inc. | Device for retrieving stents |
WO1993019803A1 (fr) * | 1992-03-31 | 1993-10-14 | Boston Scientific Corporation | Fil medical |
US20020035396A1 (en) | 1992-03-31 | 2002-03-21 | Boston Scientific Corporation, A Delaware Corporation | Tubular medical endoprostheses |
US5876448A (en) | 1992-05-08 | 1999-03-02 | Schneider (Usa) Inc. | Esophageal stent |
US6626936B2 (en) | 1997-08-01 | 2003-09-30 | Boston Scientific Scimed, Inc. | Bioabsorbable marker having radiopaque constituents |
US6792979B2 (en) | 1999-02-01 | 2004-09-21 | Board Of Regents, The University Of Texas System | Methods for creating woven devices |
US20030040772A1 (en) * | 1999-02-01 | 2003-02-27 | Hideki Hyodoh | Delivery devices |
US20020143387A1 (en) * | 2001-03-27 | 2002-10-03 | Soetikno Roy M. | Stent repositioning and removal |
US6676692B2 (en) | 2001-04-27 | 2004-01-13 | Intek Technology L.L.C. | Apparatus for delivering, repositioning and/or retrieving self-expanding stents |
US20020188344A1 (en) | 2001-06-01 | 2002-12-12 | American Medical Systems | Retrievable stent and method of use thereof |
WO2004105647A1 (fr) * | 2003-05-23 | 2004-12-09 | Scimed Life Systems, Inc. | Stents a extremites en boucle attachees |
US20050049682A1 (en) | 2003-05-23 | 2005-03-03 | Scimed Life Systems, Inc. | Stents with attached looped ends |
WO2005110286A1 (fr) * | 2004-05-14 | 2005-11-24 | Boston Scientific Limited | Méthode de réduction des profils de soudure des stents; stent muni de profils de soudure réduits et configuration d’un câble fermé |
Also Published As
Publication number | Publication date |
---|---|
US11013624B2 (en) | 2021-05-25 |
US20160175125A1 (en) | 2016-06-23 |
US20230404782A1 (en) | 2023-12-21 |
JP2008545453A (ja) | 2008-12-18 |
US20190029851A1 (en) | 2019-01-31 |
US20210251784A1 (en) | 2021-08-19 |
EP1887974B1 (fr) | 2018-04-25 |
US10111766B2 (en) | 2018-10-30 |
WO2006124541A2 (fr) | 2006-11-23 |
US10149776B2 (en) | 2018-12-11 |
US11786386B2 (en) | 2023-10-17 |
EP2666508A1 (fr) | 2013-11-27 |
EP2666508B1 (fr) | 2019-07-24 |
EP1887974A2 (fr) | 2008-02-20 |
ES2671416T3 (es) | 2018-06-06 |
US20060276887A1 (en) | 2006-12-07 |
EP3597256B1 (fr) | 2023-01-18 |
JP5008660B2 (ja) | 2012-08-22 |
WO2006124541A3 (fr) | 2009-03-05 |
US20160128853A1 (en) | 2016-05-12 |
US9265634B2 (en) | 2016-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11786386B2 (en) | Integrated stent repositioning and retrieval loop | |
US11583421B2 (en) | Stent retrieval system | |
US10265203B2 (en) | Stent retrieval member and devices and methods for retrieving or repositioning a stent | |
EP2407127B1 (fr) | Endoprothèse atraumatique dotée d'une force de déploiement réduit | |
US8025693B2 (en) | Stent-graft having flexible geometries and methods of producing the same | |
US20080009934A1 (en) | Endoprosthesis delivery system with stent holder |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN PUBLISHED |
|
AC | Divisional application: reference to earlier application |
Ref document number: 2666508 Country of ref document: EP Kind code of ref document: P Ref document number: 1887974 Country of ref document: EP Kind code of ref document: P |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20200722 |
|
RBV | Designated contracting states (corrected) |
Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20210303 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: BOSTON SCIENTIFIC MEDICAL DEVICE LIMITED |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20220829 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AC | Divisional application: reference to earlier application |
Ref document number: 1887974 Country of ref document: EP Kind code of ref document: P Ref document number: 2666508 Country of ref document: EP Kind code of ref document: P |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602006060426 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1544337 Country of ref document: AT Kind code of ref document: T Effective date: 20230215 Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: FP |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG9D |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1544337 Country of ref document: AT Kind code of ref document: T Effective date: 20230118 |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230529 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230518 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230118 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230118 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230118 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230118 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230118 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230118 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230518 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230419 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230118 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602006060426 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230118 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230118 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230118 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230118 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230118 |
|
26N | No opposition filed |
Effective date: 20231019 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230118 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20230531 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230118 Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230118 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230531 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230531 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230511 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20240418 Year of fee payment: 19 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230118 Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230531 Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230531 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IE Payment date: 20240419 Year of fee payment: 19 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20240419 Year of fee payment: 19 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20240418 Year of fee payment: 19 |